1-4 of 4
Yunfeng Shen
Close
Sort by
Journal Articles

Interim Results From a Phase II Study Of Non-Anthracycline Combination Of Oxaliplatin-Gemcitabine Plus Rituximab (R-GemOx) As First-Line Treatment In Elderly Patients With Diffuse Large B-Cell Lymphoma

Lei Fan, MD, PhD, Li Wang, MD., Ji Xu, MD., Run Zhang, M.D., Yuqiong Yang, M.D., Dongping Huang, Yunfeng Shen, Min Zhou, Liang Yu, Zhihong Zhang, Wei Xu, MD, PhD, Jianyong Li, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3034.
https://doi.org/10.1182/blood.V122.21.3034.3034
Published: 2013
Journal Articles

Clinical Study Of Dose-Adjusted EPOCH Regimen For Non-Hodgkin's Lymphoma With Hemophagocytic Lymphohistiocytosis: Preliminary Results Of An Ongoing Phase II Study

Wei Xu, MD, PhD, Lei Fan, MD, PhD, Li Wang, MD., Ji Xu, MD., Run Zhang, M.D., Yuqiong Yang, M.D., Dongping Huang, Yunfeng Shen, Min Zhou, Liang Yu, Zhihong Zhang, Jianyong Li, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4360.
https://doi.org/10.1182/blood.V122.21.4360.4360
Published: 2013
Journal Articles

The Investigation of JAK2 and C-MPL Mutations of Myeloproliferative Disorders Patiens

Jun Xia, Yunfeng Shen, Jianyong Li, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 5261.
https://doi.org/10.1182/blood.V112.11.5261.5261
Published: 2008
Journal Articles

Comparison of Combination Therapy of Imatinib with Trisenox Versus Imatinib Monotherapy for Chronic Myeloid Leukemia Patients in Chronic Phase.

Dongguang Yang, Ri Zhang, Yunfeng Shen, Xuhui Zhang, De Pei Wu
Journal: Blood
Blood (2006) 108 (11): 2159.
https://doi.org/10.1182/blood.V108.11.2159.2159
Published: 2006